Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates
WALTHAM, Mass., March 28, 2025 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, today announced ...
Sun Pharmaceutical Industries rises Friday, outperforms competitors
Sun Pharmaceutical Industries Ltd. closed 11.47% below its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.
Sun Pharma Shares Shrink After Its US Investment, Lyndra Therapeutics Inc Goes Belly Up
Sun Pharma shares dipped in the intraday trading session on Friday, March 28. The Indian equity markets are in a tight spot, ...
Ionis Pharmaceuticals enters exclusive olezarsen license agreement with Sobi
Ionis Pharmaceuticals (IONS) announced that it has entered into a license agreement under which Sobi received exclusive rights in countries ...
Sun Pharmaceutical Industries falls Wednesday, still outperforms market
Sun Pharmaceutical Industries Ltd. closed 10.33% short of its 52-week high of 1,960.20 rupees, which the company reached on ...
Carlsbad’s Ionis strikes deal with Japanese pharma worth up to $940M
Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine targeting a chronic blood disorder.